Cardiac stem cells: A promising treatment option for heart failure (Review)

Experimental and Therapeutic Medicine

Volumn 5, Issue 2, 2013, Pages 379-383

  Zhao, Xiaohui ^a   Huang, Lan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac stem cells; Cardiomyocyte; Heart failure

Indexed keywords

ALPHA ACTIN; ATAXIN 1; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CARDIOTROPHIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GRANULOCYTE COLONY STIMULATING FACTOR; ISL 1 PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MYOSIN HEAVY CHAIN BETA; SCATTER FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

CARDIAC STEM CELL; CARDIAC STEM CELL TRANSPLANTATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; MITOSIS; NONHUMAN; REVIEW; STEM CELL; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION;

EID: 84871352582     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.854     Document Type: Review

References (66)

1. Chien KR and Olson EN: Converging pathways and principles in heart development and disease: CV@CSH. Cell 110: 153-162, 2002.
2. MacLellan WR and Schneider MD: Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62: 289-319, 2000.
3. Anversa P, Rota M, Urbanek K, etal: Myocardial aging-a stem cell problem. Basic Res Cardiol 100: 482-493, 2005.
4. Beltrami AP, Barlucchi L, Torella D, etal: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114: 763-776, 2003.
5. Martin CM, Meeson AP, Robertson SM, etal: Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol265: 262-275, 2004.
6. Matsuura K, Nagai T, Nishigaki N, etal: Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. JBiol Chem 279: 11384-11391, 2004.
7. Oh H, Bradfute SB, Gallardo TD, etal: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318, 2003.
8. Linke A, Müller P, Nurzynska D, etal: Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102: 8966-8971, 2005.
9. Messina E, De Angelis L, Frati G, etal: Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95: 911-921, 2004.
10. Balsam LB, Wagers AJ, Christensen JL, etal: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673, 2004.
11. Fuchs S, Baffour R, Zhou YF, etal: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001.
12. Kamihata H, Matsubara H, Nishiue T, etal: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052, 2001.
13. Kocher AA, Schuster MD, Szabolcs MJ, etal: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
14. Orlic D, Kajstura J, Chimenti S, etal: Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
15. Schuster MD, Kocher AA, Seki T, etal: Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287: H525-H532, 2004.
16. Beltrami AP, Urbanek K, Kajstura J, etal: Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
17. Kajstura J, Leri A, Finato N, etal: Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95: 8801-8805, 1998.
18. Quaini F, Cigola E, Lagrasta C, etal: End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 75: 1050-1063, 1994.
19. Urbanek K, Quaini F, Tasca G, etal: Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100: 10440-10445, 2003.
20. Anversa P, Leri A, Rota M, etal: Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25: 589-601, 2007.
21. Olivetti G, Cigola E, Maestri R, etal: Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28: 1463-1477, 1996.
22. Anversa P, Kajstura J, Leri A and Bolli R: Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113: 1451-1463, 2006.
23. Urbanek K, Cesselli D, Rota M, etal: Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103: 9226-9231, 2006.
24. Nadal-Ginard B, Kajstura J, Leri A and Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92: 139-150, 2003.
25. Bayes-Genis A, Salido M, Solé Ristol F, etal: Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res 56: 404-410, 2002.
26. Deb A, Wang S, Skelding KA, etal: Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 107: 1247-1249, 2003.
27. Glaser R, Lu MM, Narula N and Epstein JA: Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106: 17-19, 2002.
28. Quaini F, Urbanek K, Beltrami AP, etal: Chimerism of the transplanted heart. N Engl J Med 346: 5-15, 2002.
29. Rosenthal N: Prometheus's vulture and the stem-cell promise. NEngl J Med 349: 267-274, 2003.
30. Kondo M, Wagers AJ, Manz MG, etal: Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21: 759-806, 2003.
31. Morrison SJ, Wandycz AM, Akashi K, etal: The aging of hematopoietic stem cells. Nat Med 2: 1011-1016, 1996.
32. Smart N and Riley PR: The stem cell movement. Circ Res 102: 1155-1168, 2008.
33. Sellers SE, Tisdale JF, Agricola BA, etal: The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood 97: 1888-1891, 2001.
34. Moretti A, Lam J, Evans SM and Laugwitz KL: Biology of Isl1+ cardiac progenitor cells in development and disease. Cell Mol Life Sci 64: 674-682, 2007.
35. Moretti A, Caron L, Nakano A, etal: Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle and endothelial cell diversification. Cell 127: 1151-1165, 2006.
36. Lev S, Yarden Y and Givol D: Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem 267: 15970-15977, 1992.
37. van de Rijn M, Heimfeld S, Spangrude GJ and Weissman IL: Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA 86: 4634-4638, 1989.
38. Durocher D, Charron F, Warren R, etal: The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16: 5687-5696, 1997.
39. Grépin C, Robitaille L, Antakly T and Nemer M: Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol 15: 4095-4102, 1995.
40. Yamamoto K, Burnett JC Jr, Jougasaki M, et al: Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28: 988-994, 1996.
41. Sheng Z, Pennica D, Wood WI and Chien KR: Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122: 419-428, 1996.
42. Asai S, Saito Y, Kuwahara K, etal: The heart is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun 279: 320-323, 2000.
43. Mahdavi V, Periasamy M and Nadal-Ginard B: Molecular characterization of two myosin heavy chain genes expressed in the adult heart. Nature 297: 659-664, 1982.
44. Michel T and Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
45. Bearzi C, Rota M, Hosoda T, etal: Human cardiac stem cells. Proc Natl Acad Sci USA 104: 14068-14073, 2007.
46. Urbanek K, Rota M, Cascapera S etal: Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673, 2005.
47. Anderson CD, Heydarkhan-Hagvall S, Schenke-Layland K, etal: The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury. J Surg Res 148: 164-171, 2008.
48. Rota M, Padin-Iruegas ME, Misao Y, etal: Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103: 107-116, 2008.
49. Chimenti I, Smith RR, Li TS, etal: Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106: 971-980, 2010.
50. Markel TA, Wang Y, Herrmann JL, etal: VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 295: H2308-H2314, 2008.
51. Matsuura K, Honda A, Nagai T, etal: Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119: 2204-2217, 2009.
52. Burchfield JS, Iwasaki M, Koyanagi M, etal: Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103: 203-211, 2008.
53. Gnecchi M, Zhang Z, Ni A and Dzau VJ: Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219, 2008.
54. Morimoto H, Takahashi M, Izawa A, etal: Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 99: 891-899, 2006.
55. Sadat S, Gehmert S, Song YH, etal: The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 363: 674-679, 2007.
56. Zohlnhöfer D, Dibra A, Koppara T, etal: Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol 51: 1429-1437, 2008.
57. Ballard VL: Stem cells for heart failure in the aging heart. Heart Fail Rev 15: 447-456, 2010.
58. Kretlow JD, Jin YQ, Liu W, etal: Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 9: 60, 2008.
59. Smith AL, Ellison FM, McCoy JP Jr and Chen J: c-Kit expression and stem cell factor-induced hematopoietic cell proliferation are up-regulated in aged B6D2F1 mice. J Gerontol A Biol Sci Med Sci 60: 448-456, 2005.
60. Joulin O, Petillot P, Labalette M, etal: Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol Res 56: 291-297, 2007.
61. Müller AC (eds): Wirkung auf Herzmuskelzellen aus spontan hypertensiven Ratten und nach antihypertensiver Therapie. In: Die parakrine Wirkung kardialer Progenitorzellen auf die kontraktile Funktion von Kardiomyozyten. VVB Laufersweiler Verlag Publishing, Germany, pp81-84, 2010 (In German).
62. Leri A, Kajstura J and Anversa P: Role of Cardiac Stem Cells in Cardiac Pathophysiology: Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res 109: 941-961, 2011.
63. Schächinger V, Erbs S, Elsässer A, etal: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221, 2006.
64. Wollert KC, Meyer GP, Lotz J, etal: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148, 2004.
65. Perin EC, Dohmann HF, Borojevic R, etal: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302, 2003.
66. Dimmeler S, Burchfield J and Zeiher AM: Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28: 208-216, 2008.